MIS-C: Diagnosis, Management, and Outcomes - Takeaways - MDSpire

MIS-C: Diagnosis, Management, and Outcomes

  • By

  • Christophe El Rassi

  • Roy El Darzi

  • Maria Abou Mansour

  • Mariam Arabi

  • December 19, 2025

  • 0 min

Share

  • 1

    Multisystem inflammatory syndrome in children (MIS-C) is a postinfectious hyperinflammatory disorder linked to COVID-19 infection.

  • 2

    MIS-C is characterized by persistent fever, shock, multiorgan involvement, and severe cardiovascular complications.

  • 3

    Management of MIS-C includes supportive care, hemodynamic stabilization, and immunomodulatory therapies like IVIG and corticosteroids.

  • 4

    The incidence of MIS-C is approximately 5 cases per million person-months in children following SARS-CoV-2 infection.

  • 5

    Long-term follow-up is crucial for monitoring potential cardiac, gastrointestinal, and neurologic complications post-MIS-C.

Original Source(s)

MIS-C: Diagnosis, Management, and Outcomes

  • by Christophe El Rassi, Roy El Darzi, Maria Abou Mansour, Mariam Arabi

  • December 19, 2025

Related Content

Case Report: Successful treatment of recurrent COVID-19 with intravenous immunoglobulin in a patient with rituximab-induced B-cell depletion and restoration of Fc-mediated effector functions

Assessing the association of physical distancing to avoid COVID-19 with health-related quality of life in immunocompromised adolescents: results from the cross-sectional observational EAGLE study

Permanent hypoparathyroidism following SARS-CoV-2 infection: a case report with two-year follow-up and literature review